Home › Funds › Thomasville National Bank › GILD
Thomasville National Bank position in GILD
GILEAD SCIENCES INC · Health Care
Thomasville National Bank reported holding 91,822 shares of GILD (GILEAD SCIENCES INC) in its Q2 2026 13F filing — a position valued at US$11.6M, representing 0.64% of its reported portfolio and ranking #39 among its reported holdings. Thomasville National Bank has disclosed GILD holdings in 10 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Thomasville National Bank's GILD position evolved
Thomasville National Bank first disclosed a stake in GILD in Q3 2023 at 152,562 shares (US$11.4M). The position peaked in Q4 2024 at 196,479 shares, worth US$18.1M. Across 10 filings, Thomasville National Bank increased the stake 6 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 91,822 shares valued at US$11.6M — a reduction of -17,840 shares quarter over quarter.. Notable position changes include a 45% trim in Q1 2025 (shares were roughly flat over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 152.56K | $11.43M | New |
| Q4 2023 | 156.07K | $12.64M | Add |
| Q1 2024 | 168.10K | $12.31M | Add |
| Q3 2024 | 192.15K | $16.11M | Add |
| Q4 2024 | 196.48K | $18.15M | Add |
| Q1 2025 | 107.14K | $12.00M | Reduce |
| Q2 2025 | 105.50K | $11.70M | Reduce |
| Q3 2025 | 107.25K | $11.90M | Add |
| Q4 2025 | 109.66K | $13.46M | Add |
| Q2 2026 | 91.82K | $11.60M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GILD and 13F data
GILD (GILEAD SCIENCES INC) is a Health Care company. 35 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.45B), Capital World Investors (US$5.18B), Capital World Investors (US$5.18B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GILD
- Fidelity Management & Research (FMR) 66.87M sh · $8.45B · Q2 2026
- Capital World Investors 40.99M sh · $5.18B · Q2 2026
- Capital World Investors 40.99M sh · $5.18B · Q2 2026
- Invesco Ltd 39.82M sh · $5.03B · Q2 2026
- PRICE T ROWE ASSOCIATES INC /MD/ 30.00M sh · $3.79B · Q2 2026
- Dodge & Cox 23.68M sh · $2.99B · Q2 2026
- DODGE & COX 23.68M sh · $2.99B · Q2 2026
More on Thomasville National Bank
FAQ
How long has Thomasville National Bank held GILD?
Thomasville National Bank has disclosed GILD holdings in 10 of the last 12 reported quarters, going back to Q3 2023.
What is Thomasville National Bank's current position in GILD?
As of Q2 2026, Thomasville National Bank holds 91.82K shares of GILD (GILEAD SCIENCES INC), valued at $11.60M, representing 0.64% of its reported portfolio and ranking #39.
Has Thomasville National Bank been buying or selling GILD?
In the latest 13F filing (Q2 2026), Thomasville National Bank reduced its position in GILD. The position peaked in Q4 2024 at 196.48K shares.
Which other funds hold GILD?
Other major institutional holders of GILD include Fidelity Management & Research (FMR), Capital World Investors, Capital World Investors, among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.